Study the effect of Haritakyadi Eye drops in immature senile cataract
Phase 2
- Conditions
- Health Condition 1: - Health Condition 2: H250- Age-related incipient cataract
- Registration Number
- CTRI/2021/07/034523
- Lead Sponsor
- ot applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having sign and symptoms of immature senile cataract.
Patient having vision 6/60 or more
Exclusion Criteria
Patient other than immature senile cataract.
Patient having vision less than 6/60.
Patient having any fundus pathology.
Patients with hypertension, diabetes, other cardiac problems
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effect of Haritakyadi Eye drops in sign and symptoms of immature senile cataractTimepoint: assessment done at 7 days, 15 days, 30 days
- Secondary Outcome Measures
Name Time Method To study the patalagat doshdushti (Timira) <br/ ><br>To study in detail immature senile cataract. <br/ ><br>To study beneficial effect of Ancient mode of treatment in modern era. <br/ ><br>To study the physiochemical parameters of Haritakyadi eye drops. <br/ ><br>To study the adverse effect of Haritakyadi Eye drops if any. <br/ ><br> <br/ ><br>Timepoint: 7th, 15th and 30 th days for trial medication observation and 60 th day for observation only. <br/ ><br>Total study duration is of 2 years.